Monday, March 03, 2025 | 12:04 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Drug companies move Delhi HC seeking interim relief against FDC ban

The Union Ministry of Health and Family Welfare had on August 22 issued notification banning the 156 FDC medicines saying they had no therapeutic benefits

Drug, Medicine, Medical
Premium

(Photo: Shutterstock)

Sanket Koul Delhi

Listen to This Article

A clutch of pharmaceutical companies approached the Delhi High Court on Thursday seeking interim relief against the central government’s decision to ban 156 fixed drug combination (FDC) medicines, so that they could clear the stocks lying in the market.

The Union Ministry of Health and Family Welfare had on August 22 issued notification banning the 156 FDC medicines saying they had no therapeutic benefits.

The high court, after admitting the petition, sought the government’s response by September 2.

FDCs are drugs that contain a combination of two or more active pharmaceutical ingredients (APIs) in a single form, usually manufactured and

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in